Company · CIK 0001842295 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Maze Therapeutics, Inc. · MAZE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 8, 4:20 pm EDT | Harold BernsteinPresident, R&D & CMO | 9,705 | $26.22 | $254,502 | 0 | −100% | 10b5-1 |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:27 pm EDT | Phillips CourtneyGC and Corp. Secretary | 3,993 | $26.24 | $104,766 | 7,007 | −36.3% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | Atul DandekarCSBO | 6,434 | $26.24 | $168,811 | 32,316 | −16.6% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:24 pm EDT | Jason V ColomaChief Executive Officer, Director | 22,638 | $26.24 | $593,955 | 27,362 | −45.3% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:22 pm EDT | Harold BernsteinPresident, R&D & CMO | 10,295 | $26.24 | $270,111 | 9,705 | −51.5% | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:31 pm EDT | Phillips CourtneyGC and Corp. Secretary | 11,000 | — | — | 11,000 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:29 pm EDT | Atul DandekarCSBO | 12,500 | — | — | 38,750 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:27 pm EDT | Jason V ColomaChief Executive Officer, Director | 50,000 | — | — | 50,000 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:27 pm EDT | Jason V ColomaChief Executive Officer, Director | 34,501 | $26.29 | $906,999 | 223,355 | −13.4% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:24 pm EDT | Harold BernsteinPresident, R&D & CMO | 16,141 | $26.36 | $425,512 | 0 | −100% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:24 pm EDT | Harold BernsteinPresident, R&D & CMO | 36,141 | $10.42 | $168,189 | 20,000 | — | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Aug 31, 6:32 pm EDT | Atul DandekarCSBO | 7,500 | $27.58 | $206,824 | 26,250 | −22.2% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 31, 6:32 pm EDT | Atul DandekarCSBO | 7,500 | $10.42 | $78,150 | 33,750 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 4:31 pm EDT | Phillips CourtneyGC and Corp. Secretary | 11,000 | — | — | 11,000 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:29 pm EDT | Atul DandekarCSBO | 12,500 | — | — | 12,500 | — | |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:27 pm EDT | Jason V ColomaChief Executive Officer, Director | 50,000 | — | — | 50,000 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:24 pm EDT | Harold BernsteinPresident, R&D & CMO | 36,141 | — | — | 20,000 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 31, 6:32 pm EDT | Atul DandekarCSBO | 7,500 | — | — | 14,143 | — | 10b5-1 |